RESUMO
The cobalt(II)-mediated self-assembly of the potentially tris(chelating) N,N'-2,2'-(4,4'-bithiazole)bis(oxamate) (dabtzox) ligand gives a new metal-organic supramolecular nanomagnet of formula K6Co3(dabtzox)3·8H2O·MeOH (1) featuring a unique linear triple-stranded trinuclear structure of the helicate type.
RESUMO
We herein present the synthesis, spectroscopic analysis, description of the crystal structures and magnetic properties of four new complexes of the formula [{Cu(opba)(H2O)1.2}{Cu(dmphen)(SCN)}2]·dmf (1), [{Cu(opba)}2{Cu(dmphen)Cl}4]·1.5dmf·2.5dmso (2), [{Cu(opba)}2{Cu(dmphen)Br}4]·dmf·2.3dmso (3) and [{Cu(opba)}{Cu(dmphen)(dca)}2]n (4) [H4opba = N,N'-1,2-phenylenebis(oxamic acid), dmphen = 2,9-dimethyl-1,10-phenanthroline and dca = dicyanamide anion]. 1 is a neutral tricopper(ii) complex where an inner [Cu(opba)]2- fragment adopts a bis-bidentate coordination mode towards two outer [Cu(dmphen)(NCS)]+ units. 2 and 3 are bis-trinuclear species where two oxamato-bridged [Cu(opba){Cu(dmphen)X}2] [X = Cl- (2) and Br- (3)] tricopper(ii) entities are connected by two single X ions involving the central and one of the peripheral copper(ii) ions. 4 is a neutral chain made up of oxamato-bridged [Cu(opba){Cu(dmphen)(dca)}2] fragments linked through a single end-to-end dicyanamide ligand that connects the central copper(ii) ion with one of the peripheral copper(ii) ions. Magnetic susceptibility measurements on polycrystalline samples of 1-4 in the temperature range 1.9-300 K show the occurrence of strong antiferromagnetic interactions between the copper(ii) ions through the oxamate bridge [J = -328(2) (1), -288(2) (2), -431(2) (3) and -370(1) cm-1 (4), the Hamiltonian being defined as H = -J(S1·S2 + S1·S3)] and a weak ferromagnetic coupling across the equatorial-axial exchange pathway provided by the single halide bridge [j = +3.08(3) (2) and +2.34(1) cm-1 (3)]. These values are analyzed by simple orbital symmetry considerations and compared with those reported in the literature for polynuclear copper(ii) complexes with these bridging ligands.